7 studies on PNC-27 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Recent certificates: #14859 (99.22%) · #12014 (99.146%) · #18186 (99.502%) · #18112 (99.263%) · #22439 (99.671%) · #16662 (99.622%)
Manufacturers with published third-party certificates of analysis for PNC-27. Open a vendor to see every batch we've verified.
This innovative high-yield recombinant expression system represents a significant advancement in peptide biotechnology, potentially making therapeutic peptides more accessible and affordable. By improving production e…
This research is profoundly significant because it provides compelling ex vivo evidence for PNC-27's potent anti-cancer activity in a highly relevant model using actual human patient samples. This approach offers a mo…
This research highlights PNC-27 as a promising dual-mechanism anti-cancer agent that targets both an intracellular protein (HDM-2) and the cell membrane. Its selective toxicity towards cancer cells, while sparing norm…
This study underscores the urgent need for targeted interventions to support mothers who have experienced child loss in Nigeria, ensuring they receive adequate maternal healthcare for subsequent pregnancies. Understan…
This study provides crucial insights into the molecular mechanisms governing the stability and efficacy of p53-derived anticancer peptides, highlighting the critical role of the ETFS amino acid sequence. The findings …
This conceptual framework for poptosis represents a potentially groundbreaking shift in cancer treatment strategy. By proposing a mechanism for highly selective cancer cell destruction, it addresses a major limitation…
The potential significance of PNC-27 remains entirely theoretical without empirical data on its biological interactions. Its intricate peptide structure suggests it could potentially interact with various biological t…
Free, no account — handy when you're working with PNC-27.